Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Receivables - Accured (2022 - 2025)

Perspective Therapeutics (CATX) has disclosed Revenue - Other for 5 consecutive years, with $43000.0 as the latest value for Q4 2025.

  • Quarterly Revenue - Other fell 81.62% to $43000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $884000.0 through Dec 2025, down 39.2% year-over-year, with the annual reading at $884000.0 for FY2025, 39.2% down from the prior year.
  • Receivables - Accured hit $1.0 million in Q4 2025 for Perspective Therapeutics, up from $880000.0 in the prior quarter.
  • In the past five years, Receivables - Accured ranged from a high of $1.0 million in Q4 2025 to a low of $109000.0 in Q4 2022.
  • Historically, Receivables - Accured has averaged $670666.7 across 3 years, with a median of $880000.0 in 2024.
  • Biggest five-year swings in Revenue - Other: skyrocketed 39.48% in 2024 and later crashed 81.62% in 2025.
  • Year by year, Revenue - Other stood at $337000.0 in 2023, then crashed by 30.56% to $234000.0 in 2024, then plummeted by 81.62% to $43000.0 in 2025.
  • Business Quant data shows Revenue - Other for CATX at $43000.0 in Q4 2025, $209000.0 in Q3 2025, and $290000.0 in Q2 2025.